News & Events
Sibel Blau, MD Discusses “How Oncology Practices Can Successfully Deliver Value-Based Care”, with Lalan Wilfong, MD at PCOC Conference
Sibel Blau, MD, President/CEO, Quality Cancer Care Alliance Network/Exigent Research shared QCCA’s perspective during a fireside chat titled “How Oncology Practices Can Successfully Deliver Value-Based… Sibel Blau, MD Discusses “How Oncology Practices Can Successfully Deliver Value-Based Care”, with Lalan Wilfong, MD at PCOC Conference
Sibel Blau, MD, President/CEO of the Quality Cancer Care Alliance Network (QCCA) and Medical Director of Northwest Medical Specialties, presented the different operational models used in… Dr. Sibel Blau presents the different operational models used in the ELAINE2 study at ASCO 2022.
A real-world study to evaluate the safety and efficacy of three injectable neurokinin-1 receptor antagonist formulations for the prevention of chemotherapy-induced nausea and vomiting in cancer patients
QCCA Network is pleased to announce the addition of Aaron Peevyhouse, Vice President, Real World Data. Aaron brings over a decade of oncology experience, and… QCCA Network adds Aaron Peevyhouse, VP Real World Data
Continued Growth at the Quality Cancer Care Alliance as New Jersey Hematology Oncology Associates Joins the Network
The Research Program at Highlands Oncology
American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care
Letrozole + ribociclib versus letrozole + placebo as neoadjuvant therapy for ER+ breast cancer (FELINE trial).